MUC2, the major intestinal mucin, has been suggested to carry immunoregulatory signals to favor tumor growth in the large intestine (36), and our previous study also demonstrated that overexpression of MUC2 is linked to CCRT resistance and poor prognosis in patients with rectal adenocarcinoma (10). Here, MUC2 is linked to neoplasm.